Reaction
Which drugs are most reported with Diffuse large b-cell lymphoma?
As of the last recalculation, Diffuse Large B-Cell Lymphoma appears in 7,531 FAERS reports alongside 193 co-occurring drug terms. The strongest observed disproportionality signal is POLATUZUMAB VEDOTIN (PRR 121.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.